These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2410739

  • 1. Arachidonic acid cascade and the generation of ischemia- and reperfusion-induced ventricular arrhythmias.
    Parratt JR, Coker SJ.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 5():S65-70. PubMed ID: 2410739
    [Abstract] [Full Text] [Related]

  • 2. Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion.
    Parratt JR, Coker SJ, Wainwright CL.
    J Mol Cell Cardiol; 1987 Oct; 19 Suppl 5():55-66. PubMed ID: 3323537
    [Abstract] [Full Text] [Related]

  • 3. Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances.
    Wainwright CL, Parratt JR.
    Cardiovasc Res; 1991 Feb; 25(2):93-100. PubMed ID: 1742769
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ischemia-reperfusion arrhythmias and lipids: effect of human high- and low-density lipoproteins on reperfusion arrhythmias.
    Mochizuki S, Okumura M, Tanaka F, Sato T, Kagami A, Tada N, Nagano M.
    Cardiovasc Drugs Ther; 1991 Mar; 5 Suppl 2():269-76. PubMed ID: 1906736
    [Abstract] [Full Text] [Related]

  • 8. Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ, Parratt JR.
    J Cardiovasc Pharmacol; 1983 Mar; 5(4):557-67. PubMed ID: 6193351
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.
    De Clerck F, Beetens J, Van de Water A, Vercammen E, Janssen PA.
    Thromb Haemost; 1989 Feb 28; 61(1):43-9. PubMed ID: 2526385
    [Abstract] [Full Text] [Related]

  • 11. Lack of thromboxane A2 involvement in the arrhythmias occurring during acute myocardial ischemia in dogs.
    Burke SE, Antonaccio MJ, Lefer AM.
    Basic Res Cardiol; 1982 Feb 28; 77(4):411-22. PubMed ID: 6890805
    [Abstract] [Full Text] [Related]

  • 12. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V, De Gaetano G.
    Eur J Pharmacol; 1982 Dec 03; 85(3-4):331-3. PubMed ID: 6295787
    [Abstract] [Full Text] [Related]

  • 13. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.
    Végh A, Parratt JR.
    Cardiovasc Res; 2002 Jul 03; 55(1):53-63. PubMed ID: 12062708
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M, Kinukawa M, Kanazawa T, Maruyama K, Miyagi M, Miyata H, Ujiie A.
    J Pharmacol Exp Ther; 1996 Nov 03; 279(2):877-83. PubMed ID: 8930195
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiarrhythmic effects of the thromboxane antagonist BM 13.177.
    Wainwright CL, Parratt JR.
    Eur J Pharmacol; 1987 Jan 20; 133(3):257-64. PubMed ID: 3104065
    [Abstract] [Full Text] [Related]

  • 20. The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury.
    Fiedler VB, Mardin M, Perzborn E, Grützmann R.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov 20; 331(2-3):267-74. PubMed ID: 3841382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.